Godavari Drugs (BOM:530317) 3-Year EBITDA Growth Rate : 21.70% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs 3-Year EBITDA Growth Rate?

Godavari Drugs's EBITDA per Share for the three months ended in Dec. 2023 was ₹4.66.

During the past 12 months, Godavari Drugs's average EBITDA Per Share Growth Rate was 20.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 21.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 24.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 16.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Godavari Drugs was 48.70% per year. The lowest was -14.80% per year. And the median was 28.10% per year.

Competitive Comparison of Godavari Drugs's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Godavari Drugs's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Godavari Drugs's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Godavari Drugs's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Godavari Drugs's 3-Year EBITDA Growth Rate falls into.

Godavari Drugs 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Godavari Drugs (BOM:530317) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Godavari Drugs 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Godavari Drugs (BOM:530317) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003

Website

https://www.godavaridrugs.com

Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines